What were Dr Reddys Laboratories Ltd's latest quarterly results?
Dr Reddys Laboratories Ltd's latest quarterly results (Mar 2026) show
- PAT Growth YoY: -86.1%
- Revenue Growth YoY: -11.5%
- Operating Margin: 5.0%
Dr Reddys Laboratories Ltd: Stock Analysis & Fundamentals
Updated this weekDr Reddys Laboratories Ltd (Pharma - Formulators) — fundamental analysis, earnings data, and key metrics. PE: 26.9. ROE: 11.8%. This stock is not currently in the Nifty 500 momentum outperformers list.
Dr Reddys Laboratories Ltd Key Facts
What's Happening
💪Debt reduced 24% YoY — balance sheet strengthening
🌐FII stake decreased 2.8% this quarter
🏛️DII accumulation — stake up 6.5%
Key Numbers
Current Price
₹1,350
Dividend Yield
0.59%
Market Cap
1.1L Cr
Valuation
N/AOther Top Pharma - Formulators Stocks Beating Nifty 500
Frequently Asked Questions: Dr Reddys Laboratories Ltd
Based on publicly available financial data. This is educational research, not investment advice.
What is Dr Reddys Laboratories Ltd's current PE ratio?
Dr Reddys Laboratories Ltd's current PE ratio is 26.9x.
- Current PE: 26.9x
- Market Cap: 1.1 Lakh Cr
- Dividend Yield: 0.59%
What is Dr Reddys Laboratories Ltd's price-to-book ratio?
Dr Reddys Laboratories Ltd's price-to-book ratio is 3.0x.
- Price-to-Book (P/B): 3.0x
- Book Value per Share: ₹454
- Current Price: ₹1350
Is Dr Reddys Laboratories Ltd a fundamentally strong company?
Dr Reddys Laboratories Ltd's fundamental strength based on key financial ratios
- Return on Capital (ROCE): 14.0%
Is Dr Reddys Laboratories Ltd debt free?
Dr Reddys Laboratories Ltd has a debt-to-equity ratio of N/A.
- Total Debt: ₹8,000 Cr
What is Dr Reddys Laboratories Ltd's return on equity (ROE) and ROCE?
Dr Reddys Laboratories Ltd's return ratios over recent years
- FY2024: ROCE 27.0%
- FY2025: ROCE 23.0%
- FY2026: ROCE 14.0%
Is Dr Reddys Laboratories Ltd's cash flow positive?
Dr Reddys Laboratories Ltd's operating cash flow is positive (FY2026).
- Cash from Operations (CFO): ₹6,000 Cr
- Free Cash Flow (FCF): ₹-875 Cr
- CFO/PAT Ratio: 136% (strong cash conversion)
What is Dr Reddys Laboratories Ltd's dividend yield?
Dr Reddys Laboratories Ltd's current dividend yield is 0.59%.
- Dividend Yield: 0.59%
- Current Price: ₹1350
Who holds Dr Reddys Laboratories Ltd shares — promoters, FII, DII?
Dr Reddys Laboratories Ltd's shareholding pattern (Mar 2026)
- Promoters: 26.6%
- FII (Foreign): 21.1%
- DII (Domestic): 30.7%
- Public: 21.3%
Is promoter holding increasing or decreasing in Dr Reddys Laboratories Ltd?
Dr Reddys Laboratories Ltd's promoter holding has decreased recently.
- Current Promoter Holding: 26.6% (Mar 2026)
- Previous Quarter: 26.6% (Dec 2025)
- Change: -0.01% (decreasing — worth monitoring)
Is Dr Reddys Laboratories Ltd a new momentum entry or an established outperformer?
Dr Reddys Laboratories Ltd is an established outperformer with 1 weeks of consecutive Nifty 500 outperformance.
Is Dr Reddys Laboratories Ltd worth studying for long term investment?
Based on quantitative research signals, here is why Dr Reddys Laboratories Ltd may be worth studying
- Cash flow is positive — CFO ₹6,000 Cr
What is the investment thesis for Dr Reddys Laboratories Ltd?
Dr Reddys Laboratories Ltd investment thesis summary:
What is the future outlook for Dr Reddys Laboratories Ltd?
Dr Reddys Laboratories Ltd's forward outlook based on current data signals
- Insufficient data for a forward assessment — monitoring for more signals
The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.